Overlap between EEC and AEC syndrome and immunodeficiency in a preterm infant with a TP63 variant

Kjell Helenius1, Liisa Ojala2, Leena Kainulainen1

  • 1Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.

Insights

TP63 gene variants cause overlapping syndromes like EEC and AEC. This case highlights a novel cardiac finding and immune deficiency in a patient with TP63-related disorders, emphasizing complex care needs.

Area of Science:

  • Genetics
  • Developmental Biology
  • Clinical Medicine

Background:

  • Pathogenic variants in the TP63 gene are associated with a spectrum of developmental disorders, including ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome and ankyloblepharon-ectodermal dysplasia-clefting (AEC) syndrome.
  • Historically, TP63-related phenotypes have been classified into distinct syndromes based on clinical presentation and variant location, though significant overlap exists.
  • Understanding the genotype-phenotype correlations in TP63-related disorders is crucial for accurate diagnosis and management.

Observation:

  • We report a patient presenting with overlapping features of EEC and AEC syndromes, including cleft lip and palate, split feet, ectropion, and skin/corneal erosions.
  • The patient harbors a de novo heterozygous pathogenic variant, c.1681T>C, p.(Cys561Arg), in exon 13 of the TP63 gene.
  • Novel findings in this patient include cardiac compartment enlargement with secondary mitral insufficiency and a rare occurrence of immune deficiency.

Findings:

  • The identified TP63 variant (c.1681T>C, p.(Cys561Arg)) is associated with a complex phenotype that bridges distinct previously defined syndromes.
  • The co-occurrence of cardiac abnormalities and immune deficiency expands the known clinical spectrum of TP63-related disorders.
  • Prematurity and very low birth weight further complicated the clinical course and management.

Implications:

  • This case underscores the phenotypic variability and significant overlap in TP63-related disorders, challenging traditional syndrome classifications.
  • The novel cardiac and immune findings necessitate a broader diagnostic consideration for TP63 variants.
  • Effective management requires a multidisciplinary approach to address the diverse and complex clinical manifestations, including potential long-term cardiac and immunological surveillance.